[go: up one dir, main page]

PL1660097T3 - Kompozycja fizjologicznie czynna na bazie fosfatydyloseryny - Google Patents

Kompozycja fizjologicznie czynna na bazie fosfatydyloseryny

Info

Publication number
PL1660097T3
PL1660097T3 PL04764814T PL04764814T PL1660097T3 PL 1660097 T3 PL1660097 T3 PL 1660097T3 PL 04764814 T PL04764814 T PL 04764814T PL 04764814 T PL04764814 T PL 04764814T PL 1660097 T3 PL1660097 T3 PL 1660097T3
Authority
PL
Poland
Prior art keywords
components
physiologically active
weight
serine
component
Prior art date
Application number
PL04764814T
Other languages
English (en)
Inventor
Martin Purpura
Ralf Jäger
Roland Rabeler
Hans-Ullrich Hoppe
Original Assignee
Cargill Texturizing Solutions Deutschland Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34223337&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1660097(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cargill Texturizing Solutions Deutschland Gmbh & Co Kg filed Critical Cargill Texturizing Solutions Deutschland Gmbh & Co Kg
Publication of PL1660097T3 publication Critical patent/PL1660097T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL04764814T 2003-09-04 2004-09-03 Kompozycja fizjologicznie czynna na bazie fosfatydyloseryny PL1660097T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10340740A DE10340740A1 (de) 2003-09-04 2003-09-04 Physiologisch aktive Zusammensetzung auf Phosphatidylserin-Basis
EP04764814A EP1660097B1 (de) 2003-09-04 2004-09-03 Physiologisch aktive zusammensetzung auf phosphatidylserin-basis
PCT/EP2004/009862 WO2005023271A1 (de) 2003-09-04 2004-09-03 Physiologisch aktive zusammensetzung auf phosphatidylserin-basis

Publications (1)

Publication Number Publication Date
PL1660097T3 true PL1660097T3 (pl) 2009-07-31

Family

ID=34223337

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04764814T PL1660097T3 (pl) 2003-09-04 2004-09-03 Kompozycja fizjologicznie czynna na bazie fosfatydyloseryny

Country Status (9)

Country Link
US (1) US20070009590A1 (pl)
EP (1) EP1660097B1 (pl)
JP (1) JP2007504197A (pl)
AT (1) ATE422160T1 (pl)
DE (2) DE10340740A1 (pl)
DK (1) DK1660097T3 (pl)
ES (1) ES2318321T3 (pl)
PL (1) PL1660097T3 (pl)
WO (1) WO2005023271A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005003865A1 (de) * 2005-01-27 2007-05-10 Bioghurt Biogarde Gmbh & Co. Kg Phosphatidylserin-basierte Zusammensetzung zur Steigerung der Gehirnfunktion
EP1896074A4 (en) * 2005-05-25 2009-04-22 Liponex Inc PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CORONARY ARTERY DISEASE
ITPD20050164A1 (it) 2005-05-30 2006-11-30 Fidia Farmaceutici Processo per la preparazione e l'isolamento di fosfatidi
AR057042A1 (es) * 2005-05-31 2007-11-14 Arla Foods Amba Fracciones de leche enriquecidas con fosfatidilserina para la formulacion de alimentos funcionales
WO2007059762A1 (de) * 2005-11-25 2007-05-31 Gisela Susilo Kombinationspräparate enthaltend physiologische zellmembran-bestandteile, einschliesslich phosphatidylserin, cholin und ein pyrimidinnukleos/tid
DE102007030495A1 (de) * 2007-06-30 2009-01-15 Alzchem Trostberg Gmbh Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der Gedächtnisleistung, der Merkfähigkeit, des Langzeitgedächtnisses und zur Vorbeugung geistiger Ermüdungszustände
US20100081694A1 (en) * 2008-09-30 2010-04-01 Epax As Composition comprising at least one ppar agonist and a lipid component
JP6024942B2 (ja) * 2012-02-29 2016-11-16 株式会社福山こめ酢 テストステロン分泌促進剤、抗疲労剤及びその製造方法と利用
WO2015163316A1 (ja) * 2014-04-22 2015-10-29 味の素株式会社 末梢神経障害の予防又は改善用組成物
JP2018537503A (ja) * 2015-12-16 2018-12-20 アケリオス セラピューティクス，インコーポレーテッド 末梢神経障害を治療するための方法及び組成物
ES2952038T3 (es) * 2016-04-05 2023-10-26 Univ New York State Res Found Composiciones que contienen fosfoserina para la inducción de la tolerancia inmune
JP6252922B2 (ja) * 2016-09-27 2017-12-27 ビーエイチエヌ株式会社 テストステロン分泌促進剤、抗疲労剤及びその製造方法と利用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2437834A1 (fr) * 1978-10-04 1980-04-30 Lejeune Jerome Compositions pharmaceutiques a base de l-serine ou de glycine
US4221784A (en) * 1979-04-05 1980-09-09 Massachusetts Institute Of Technology Process and composition for treating disorders by administering lecithin
JPH01135720A (ja) * 1987-11-20 1989-05-29 Eisai Co Ltd 神経線維再生剤
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
JPH0717855A (ja) * 1992-09-02 1995-01-20 Maruha Corp 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤、痴呆治療剤、または脳機能改善効果を有する機能性食品
JP3053537B2 (ja) * 1994-11-08 2000-06-19 株式会社ヤクルト本社 脳機能改善剤
US6310097B1 (en) * 1997-07-28 2001-10-30 Riken Protecting and survival promoting agent for central nervous cell
US6733985B1 (en) * 1999-05-19 2004-05-11 International Technidyne Corporation Preparation of stable liquid and dried synthetic prothrombin time reagents
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
DE10142014B4 (de) * 2001-08-28 2004-11-11 Degussa Bioactives Deutschland Gmbh & Co. Kg Verfahren zur Herstellung von Phosphatidylserin
NL1019368C2 (nl) * 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
US20030225031A1 (en) * 2002-05-21 2003-12-04 Quay Steven C. Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid
IL150240A (en) * 2002-06-16 2005-07-25 Lipogen Ltd Infant formula supplemented with phospholipids
US7070825B2 (en) * 2002-09-10 2006-07-04 Abbott Laboratories Infant formula
US20050158835A1 (en) * 2004-01-21 2005-07-21 Su Chen Preparation of highly polyunsaturated fatty acid-containing phosphatidylserine and phosphatidic acid

Also Published As

Publication number Publication date
EP1660097B1 (de) 2009-02-04
ES2318321T3 (es) 2009-05-01
EP1660097A1 (de) 2006-05-31
DE502004008949D1 (de) 2009-03-19
WO2005023271A1 (de) 2005-03-17
US20070009590A1 (en) 2007-01-11
JP2007504197A (ja) 2007-03-01
DE10340740A1 (de) 2005-03-31
DK1660097T3 (da) 2009-03-30
ATE422160T1 (de) 2009-02-15

Similar Documents

Publication Publication Date Title
WO2002080860A3 (en) Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
PL1660097T3 (pl) Kompozycja fizjologicznie czynna na bazie fosfatydyloseryny
IL186788A0 (en) Nutritional supplement for hiv patients
MX2010006199A (es) Composicion nutricional enterica liquida basada en caseina micelar, densa en cuanto a proteina.
PL345163A1 (en) Sitostand formulation with emulsifier to reduce cholesterol absorption
WO2003013497A1 (en) Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
WO2002043659A3 (en) Composition containing statins and calcium for improved cardiovascular health
WO2005046580A3 (en) Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism
WO2009037562A3 (en) Nutritional supplement formulations and fortified foods comprising such supplements
WO2008120711A1 (ja) タミバロテンカプセル剤
MXPA04001129A (es) Mezclas de lipidos y productos de alimento que contienen acido graso oleico y acidos grasos omega-6, disenadas para incrementar el nivel intramiocelular de lipidos.
DE602004004905D1 (de) Mit calcium angereicherte kleinkindernährmittel auf sojabasis
EP1466602A4 (en) ORGAN FIBROSIS INHIBITORS
AR025320A1 (es) Composicion liquida para mejorar el pan
Hiratsuka et al. Lipid class and fatty acid composition of phospholipids from the gonads of skipjack tuna
PL367812A1 (pl) Akywne składniki alfa-ketoglutaranu i kompozycje je zawierające
ATE399471T1 (de) Formulierung auf phospholipidbasis
AU2003224107A1 (en) Soluble composition containing sporopollenin and the use thereof
WO2007107835A3 (en) Stable liquid formulations of antiepileptic agents
CA2556520A1 (en) Chromium-fatty acid compounds and methods of making and using thereof
WO2003053163A3 (fr) Composition de sel pauvre en chlorure de sodium et riche en sel organique de potassium et ses utilisations
BRPI0506456A (pt) composição de alimento com sabor
WO2007002897A8 (en) Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for treatment of cardiovascular disease
MXPA05008860A (es) Composiciones farmaceuticas estabilizadas de safingol y metodos para utilizar las mismas.
ITRM20050592A1 (it) Composizione lipidica che presenta proprieta' nutrizionali ed organolettiche di interesse.